Literature DB >> 8833446

Addictive drugs and brain stimulation reward.

R A Wise1.   

Abstract

Direct electrical or chemical stimulation of specific brain regions can establish response habits similar to those established by natural rewards such as food or sexual contact. Cocaine, mu and delta opiates, nicotine, phencyclidine, and cannabis each have actions that summate with rewarding electrical stimulation of the medial forebrain bundle (MFB). The reward-potentiating effects of amphetamine and opiates are associated with central sites of action where these drugs also have their direct rewarding effects, suggesting common mechanisms for drug reward per se and for drug potentiation of brain stimulation reward. The central sites at which these and perhaps other drugs of abuse potentiate brain stimulation reward and are rewarding in their own right are consistent with the hypothesis that the laboratory reward of brain stimulation and the pharmacological rewards of addictive drugs are habit forming because they act in the brain circuits that subserve more natural and biologically significant rewards.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833446     DOI: 10.1146/annurev.ne.19.030196.001535

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  213 in total

1.  Behavioral screening for cocaine sensitivity in mutagenized zebrafish.

Authors:  T Darland; J E Dowling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

Authors:  Q Wu; M E Reith; M J Kuhar; F I Carroll; P A Garris
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Xing-Xiang Peng; Seth Concors; Casey Farin; Elena Lascu; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2011-12-07       Impact factor: 4.530

Review 4.  The neural circuitry of reward and its relevance to psychiatric disorders.

Authors:  David T Chau; Robert M Roth; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

5.  The biology of happiness. Chasing pleasure and human destiny.

Authors:  Ladislav Kováč
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

6.  Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

7.  Presynaptic glycine receptors on GABAergic terminals facilitate discharge of dopaminergic neurons in ventral tegmental area.

Authors:  Jiang-Hong Ye; Fushun Wang; Kresimir Krnjevic; Weizhen Wang; Zhi-Gang Xiong; Jingli Zhang
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

Review 9.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

10.  Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Authors:  A Leslie Morrow; C J Malanga; Eric W Fish; Buddy J Whitman; Jeff F DiBerto; J Elliott Robinson
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.